BabyOrgano has secured fresh backing as it looks to push deeper into India’s growing natural wellness market for children. The Ahmedabad-based startup has raised Rs 20 crore in a pre-Series A round led by RPSG Capital Ventures, with existing investor Sauce.vc doubling down on its bet.
The company plans to channel the new capital into three fronts: building out its product pipeline, strengthening marketing, and tightening operations for scale. Internally, the team has set an ambitious target of touching Rs 100 crore in revenue by FY27, a milestone they believe is within reach as more parents turn to Ayurveda-focused solutions.
BabyOrgano was founded in 2020 by Riddhi and Ripul Sharma with a simple promise: everyday health products for children that rely on traditional Ayurvedic formulations rather than synthetic alternatives. Over the past four years, the brand has quietly built a sizable base of more than one million parents, helped by strong repeat buying behaviour that the company says sits above 40 percent.
Its range spans immunity boosters, cough and cold remedies, and daily wellness products. The lineup includes Swarnaprashan drops for immunity, Cold Relief Roll-On, Cough Syrup, Sitopaladi Churna, Chocovita milk mix, and a growing set of Ayurvedic gummies. BabyOrgano sells across major online marketplaces as well as offline retail, with plans to widen this footprint significantly.
The funds will also support work on its processes and supply chain, a critical area as the company prepares for broader national distribution. With competition rising from players like Mamaearth’s kids range, The Moms Co., Mother Sparsh, Dabur, Himalaya BabyCare, Chicco’s natural line, and Kapiva Kids, BabyOrgano is positioning itself as a brand rooted firmly in Ayurveda yet accessible to modern parents.
The new investment sets the stage for BabyOrgano to strengthen that positioning while accelerating its push across India.
